spacer
home > pmps > spring 2018 > aiding pharma in airfreight
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Aiding Pharma in Airfreight

Setting up a quality cold chain in the airfreight of time- and temperaturesensitive pharmaceuticals is not an easy task. Airfreight is known for its unique conditions.

Airfreight cargo is subjected to the local weather conditions, sunshine or solar power on the products, greenhouse effects, wind chill, etc, and extreme temperature environments (hot and cold), especially on tarmac locations where the airplanes are loaded in open-air. Cost-efficiency is another consideration, especially on low-price products and bigger volumes. Also, what about regulations and laws or norms, what about processes at the actors so the products are handled correctly, and so on? These are all questions that are challenged within the complete airfreight industry to create an efficient quality cold chain from shipper to receiver.

To offer a possible solution, the company Krautz-Temax engineered a unique thermal blanket that offers a high-performing thermal resistance (hot and cold), offers resistance against solar power and greenhouse effects, has a minimal payload impact, offers a Good Distribution Practice-compliant solution, and is fully recyclable and even reproducible to raw material level, guaranteeing a minimal impact on the ecological footprint.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ludo Claes is Head of Global Quality Assurance: Cold Chain and Project Management at Krautz-TEMAX and has been developing cold chain solutions since 1995.
spacer
Ludo Claes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated Minus 40 degrees C Facility

Philadelphia, USA – August 29, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, Clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce the completion of a purpose built -40°C storage and distribution facility at its North American Clinical Services Center of Excellence.
More info >>

White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

 
Industry Events

6th Annual Single Cell Analysis Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement